The latest innovations in medical research will be showcased at Royal Brompton & Harefield NHS Foundation Trust’s seventh annual heart and lung research open day on 3 July 2018.
The trust’s medical professionals, researchers, patients, their families and volunteers play a leading role in global research with recent research breakthroughs including:
- evidence that new cystic fibrosis drug Orkambi gives improved lung function and fewer side effects for patients
- discovery of a new gene linked to the rare lung condition primary ciliary dyskinesia (PCD) which can cause permanent lung damage in children
- confirmation that the revolutionary use of valves in the lungs of patients who suffer from chronic obstructive pulmonary disease (COPD) is an effective treatment
Visitors will learn about research studies carried out at Royal Brompton and Harefield hospitals, in which hundreds of patients and healthy volunteers participate each year, and find out how this research leads to significant medical breakthroughs and the development of new treatments.
Attendees will be given the chance to see a practical demonstration of how an implantable lung valve works, and an opportunity to construct heart muscle structures from extendable ‘lazy’ tongs.
Visitors can even take part in a mock clinical trial, which involves sampling chocolate, and find out about some of the latest research through other interactive demonstrations, activities, stands and round-table discussions.
Jenny Rivers, associate director of research, said: “Research underpins our clinical work at the Trust. We are committed to finding and developing new treatments for heart and lung disease – for today’s patients and for future generations – and we are looking forward to sharing our latest work during what should be a fun and informative day.”
The event will take place from 11 am until 2.00 pm on Tuesday 3 July in the main reception and seminar rooms at Royal Brompton Hospital, Sydney Street, London SW3 6NP. There is no need to book.